|
| | 3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]- Basic information |
| Product Name: | 3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]- | | Synonyms: | 3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]-;3-Azetidineacetonitrile,1-(ethylsulfony)-3-(4-(7-(hydroxymethyl)-7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)-;N-7-Hydroxymethyl Baricitinib;2-(1-(ethylsulfonyl)-3-(4-(7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile;Ruxolitinib Hydroxy ImpurityQ: What is
Ruxolitinib Hydroxy Impurity Q: What is the CAS Number of
Ruxolitinib Hydroxy Impurity;Baricitinib impurity 03;Barrectinib impurity 5;Estazolam Impurity 7 | | CAS: | 1187595-89-6 | | MF: | C17H19N7O3S | | MW: | 401.44 | | EINECS: | | | Product Categories: | | | Mol File: | 1187595-89-6.mol | ![3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]- Structure](CAS/20210111/GIF/1187595-89-6.gif) |
| | 3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]- Chemical Properties |
| Boiling point | 730.8±70.0 °C(Predicted) | | density | 1.55±0.1 g/cm3(Predicted) | | pka | 10.96±0.10(Predicted) |
| | 3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]- Usage And Synthesis |
| Uses | 2-(1-(Ethylsulfonyl)-3-(4-(7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile is an impurity of Baricitinib (B118690), which is a JAK1 and JAK2 inhibitor and has been studied as a promising treatment for rheumatoid arthritis. |
| | 3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]- Preparation Products And Raw materials |
|
